Perennial Advisors, LLC Novartis Ag Transaction History

Perennial Advisors, LLC

  • $491 Million
  • Q1 2025

A detailed history of Perennial Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Perennial Advisors, LLC holds 42,016 shares of NVS stock, worth $4.77 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
42,016
Previous 41,171 2.05%
Holding current value
$4.77 Million
Previous $4.01 Million 16.9%
% of portfolio
0.95%
Previous 0.89%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 14, 2025
BUY
$97.14 - $115.57 $82,083 - $97,656
845 Added 2.05%
42,016 $4.68 Million
Q4 2024

Feb 21, 2025
BUY
$96.78 - $117.18 $331,761 - $401,693
3,428 Added 9.08%
41,171 $4.01 Million
Q2 2024

Jul 23, 2024
BUY
$92.57 - $107.37 $191,527 - $222,148
2,069 Added 5.8%
37,743 $4.02 Million
Q1 2024

Apr 10, 2024
SELL
$95.27 - $108.47 $11,051 - $12,582
-116 Reduced 0.32%
35,674 $3.45 Million
Q4 2023

Jan 25, 2024
BUY
$92.27 - $101.54 $65,603 - $72,194
711 Added 2.03%
35,790 $3.61 Million
Q3 2023

Oct 17, 2023
BUY
$94.73 - $105.13 $44,617 - $49,516
471 Added 1.36%
35,079 $3.57 Million
Q2 2023

Aug 01, 2023
SELL
$92.52 - $104.91 $68,464 - $77,633
-740 Reduced 2.09%
34,608 $3.49 Million
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $24,809 - $28,771
310 Added 0.88%
35,348 $3.25 Million
Q4 2022

Jan 31, 2023
SELL
$75.55 - $92.52 $36,792 - $45,057
-487 Reduced 1.37%
35,038 $3.18 Million
Q3 2022

Nov 09, 2022
BUY
$74.61 - $87.26 $151,831 - $177,574
2,035 Added 6.08%
35,525 $2.7 Million
Q2 2022

Aug 09, 2022
BUY
$80.52 - $93.75 $110,473 - $128,625
1,372 Added 4.27%
33,490 $2.83 Million
Q1 2022

Apr 27, 2022
SELL
$80.11 - $90.62 $5,046 - $5,709
-63 Reduced 0.2%
32,118 $2.82 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $164,102 - $181,459
-2,059 Reduced 6.01%
32,181 $2.82 Million
Q3 2021

Nov 08, 2021
BUY
$81.78 - $95.14 $196,026 - $228,050
2,397 Added 7.53%
34,240 $2.8 Million
Q2 2021

Aug 13, 2021
BUY
$85.24 - $94.15 $108,936 - $120,323
1,278 Added 4.18%
31,843 $2.91 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $79,826 - $94,137
956 Added 3.23%
30,565 $2.61 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $58,396 - $70,633
748 Added 2.59%
29,609 $2.8 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $158,283 - $175,357
1,927 Added 7.15%
28,861 $2.51 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $379,561 - $427,259
4,690 Added 21.08%
26,934 $2.35 Million
Q1 2020

May 19, 2020
BUY
$70.67 - $99.01 $996,376 - $1.4 Million
14,099 Added 173.1%
22,244 $1.83 Million
Q1 2020

May 19, 2020
SELL
$70.67 - $99.01 $781,610 - $1.1 Million
-11,060 Reduced 57.59%
8,145 $593,000
Q4 2019

Jan 23, 2020
BUY
$84.35 - $95.37 $4,133 - $4,673
49 Added 0.26%
19,205 $1.82 Million
Q3 2019

Nov 05, 2019
BUY
$85.54 - $94.26 $144,990 - $159,770
1,695 Added 9.71%
19,156 $1.67 Million
Q2 2019

Jul 18, 2019
BUY
$75.4 - $92.8 $162,788 - $200,355
2,159 Added 14.11%
17,461 $1.59 Million
Q1 2019

Apr 30, 2019
BUY
$75.32 - $86.15 $122,018 - $139,563
1,620 Added 11.84%
15,302 $1.47 Million
Q4 2018

Jan 29, 2019
BUY
$73.66 - $82.02 $109,385 - $121,799
1,485 Added 12.18%
13,682 $1.17 Million
Q3 2018

Nov 05, 2018
BUY
$66.94 - $77.43 $2,008 - $2,322
30 Added 0.25%
12,197 $1.05 Million
Q2 2018

Aug 10, 2018
BUY
$64.91 - $73.36 $30,572 - $34,552
471 Added 4.03%
12,167 $919,000
Q1 2018

Apr 24, 2018
BUY
$70.39 - $84.15 $64,758 - $77,418
920 Added 8.54%
11,696 $946,000
Q4 2017

Jan 29, 2018
BUY
$72.33 - $77.64 $56,345 - $60,481
779 Added 7.79%
10,776 $905,000
Q3 2017

Oct 30, 2017
BUY
$74.14 - $77.27 $741,177 - $772,468
9,997
9,997 $858,000

Others Institutions Holding NVS

# of Institutions
1,505
Shares Held
129M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $244B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Perennial Advisors, LLC Portfolio

Follow Perennial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email